4//SEC Filing
TEMPLETON RICHARD K 4
Accession 0001127602-25-007118
CIK 0000097476other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:39 PM ET
Size
27.2 KB
Accession
0001127602-25-007118
Insider Transaction Report
Form 4
TEMPLETON RICHARD K
DirectorChairman, President & CEO
Transactions
- Exercise/Conversion
Common Stock
2025-02-25$52.93/sh+97,000$5,134,210→ 506,089 total - Sale
Common Stock
2025-02-25$200.06/sh−33,120$6,625,891→ 471,082 total - Sale
Common Stock
2025-02-25$200.95/sh−49,762$9,999,485→ 421,320 total - Sale
Common Stock
2025-02-25$201.86/sh−12,231$2,469,010→ 409,089 total - Exercise/Conversion
Common Stock
2025-02-26$52.93/sh+97,000$5,134,210→ 506,089 total - Sale
Common Stock
2025-02-26$198.35/sh−34,966$6,935,621→ 411,814 total - Sale
Common Stock
2025-02-26$199.15/sh−2,725$542,685→ 409,089 total - Exercise/Conversion
NQ Stock Option (Right to Buy)
2025-02-25−97,000→ 198,557 totalExercise: $52.93Exp: 2026-01-29→ Common Stock (97,000 underlying) - Exercise/Conversion
NQ Stock Option (Right to Buy)
2025-02-26−97,000→ 101,557 totalExercise: $52.93Exp: 2026-01-29→ Common Stock (97,000 underlying) - Sale
Common Stock
2025-02-25$198.99/sh−1,887$375,503→ 504,202 total - Sale
Common Stock
2025-02-26$196.55/sh−15,018$2,951,809→ 491,071 total - Sale
Common Stock
2025-02-26$197.45/sh−44,291$8,745,453→ 446,780 total
Holdings
- 12,681.05(indirect: By Trust)
Common Stock
- 307.94(indirect: By Trust)
Common Stock
- 48,840(indirect: By Children)
Common Stock
Footnotes (12)
- [F1]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $198.5 to $199.29. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
- [F10]Estimated shares attributable to TI Universal Profit Sharing Account as of 12/31/2024. (Interests in this account are denominated in units. Consequently, share amount shown is an estimate.) This statement does not include changes in beneficial ownership of shares held in such account occurring after 12/31/2024 that are eligible for deferred reporting on Form 5.
- [F11]Shares held in trusts for benefit of children; beneficial ownership by reporting person disclaimed.
- [F12]The option became exercisable in four equal annual installments beginning on January 29, 2017.
- [F2]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $199.52 to $200.515. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
- [F3]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $200.52 to $201.51. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
- [F4]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $201.52 to $202.5. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
- [F5]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $195.98 to $196.9775. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
- [F6]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $196.98 to $197.975. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
- [F7]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $197.98 to $198.975. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
- [F8]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $198.98 to $199.335. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
- [F9]Estimated shares attributable to TI 401(k) Account as of 12/31/2024. (Interests in this account are denominated in units. Consequently, share amount shown is an estimate.) This statement does not include changes in beneficial ownership of shares held in this account occurring after 12/31/2024 that are eligible for deferred reporting on Form 5.
Documents
Issuer
TEXAS INSTRUMENTS INC
CIK 0000097476
Entity typeother
Related Parties
1- filerCIK 0001193470
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:39 PM ET
- Size
- 27.2 KB